TRXPF Stock UPDATES Torii Pharmaceutical (TRXPF) 29.9500 09/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Torii Pharmaceutical (TRXPF) 29.9500 $TRXPF

ALK's Partner for Japan Announces Trial Results for House Dust Mite SLIT-Tablet
GlobeNewswire - Mon Jun 16, 2:09AM CDT
Based on the available data, Torii expects to submit a registration application to the authorities within the next six-to-ten months.

ALK's Partner for Japan Reports Positive Trial Results for House Dust Mite SLIT-tablet
GlobeNewswire - Mon Mar 10, 2:10AM CDT
ALK (ALKB C / OMX: ALK B / AKABY / AKBLF) today announced that its partner for Japan, Torii Pharmaceutical Co., Ltd. (TSE: 4551), has reported positive results from its Phase II/III trial into ALK's sublingual allergy immunotherapy tablet (SLIT-tablet) for house dust mite-induced allergic rhinitis (hay fever).

Cedar Pollen Allergy - Pipeline Review, H2 2013 Research Report
M2 - Wed Feb 12, 3:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/f3sxtk/cedar_pollen) has announced the addition of the "Cedar Pollen Allergy - Pipeline Review, H2 2013" report to their offering. 'Cedar Pollen Allergy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cedar Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cedar Pollen Allergy. Scope - A snapshot of the global therapeutic scenario for Cedar Pollen Allergy. - A review of the Cedar Pollen Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Cedar Pollen Allergy pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Cedar Pollen Allergy Overview Therapeutics Development Cedar Pollen Allergy - Pipeline Products Glance Late Stage Products Clinical Stage Products Early Stage Products Cedar Pollen Allergy - Therapeutics Assessment Drug Profiles TO-194SL - Drug Profile TAC-201 - Drug Profile Cry J1-galactomannan Conjugate - Drug Profile JRC-LAMP Vax - Drug Profile TO-206 - Drug Profile Pollinex Quattro Japanese Cedar - Drug Profile RGI-1001 - Drug Profile Japanese Cedar Pollen Tablet - Drug Profile Japanese Cedar Hypoallergenic Vaccine - Drug Profile AllerJ - Drug Profile Cedar Pollen Vaccine - Drug Profile Vaccine For Japanese Cedar Pollen Allergy - Drug Profile Featured News & Press Releases Appendix Companies Mentioned Taiho Pharmaceutical Co., Ltd. Allergy Therapeutics plc Stallergenes S.A. Torii Pharmaceutical Co., Ltd. Anergis SA REGiMMUNE Corporation Immunomic Therapeutics, Inc. Biomay AG Adiga Life Sciences Inc. For more information visit http://www.researchandmarkets.com/research/f3...dar_pollen About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Keryx Biopharmaceuticals wins marketing approval in Japan of Ferric Citrate, triggering milestone payment
M2 - Mon Jan 20, 5:50AM CST
US-based pharmaceutical company Keryx Biopharmaceuticals Inc (KERX) said on Friday that its Japanese partner, Japan Tobacco Inc (JT), has received manufacturing and marketing approval of ferric citrate from the Japanese Ministry of Health, Labour and Welfare.

Keryx Biopharmaceuticals Announces Marketing Approval of Ferric Citrate in Japan
PR Newswire Europe - Fri Jan 17, 7:01AM CST
- Marketing Approval Triggers Milestone Payment to Keryx

Turnitin Webcasts to Address Plagiarism Prevention and Improving Critical Thinking Skills
PR Newswire - Tue Jan 07, 10:00AM CST
Turnitin, the leader in originality checking and online grading, today announced its Winter 2014 schedule of free 30-minute webcasts with a focus on using technology to provide impactful feedback to students and reduce incidents of plagiarism. The popular weekly series had nearly 25,000 registrants for the live 30-minute sessions in 2013. Another 18,000 educators viewed the recorded sessions last year.

Cedar Pollen Allergy - Pipeline Review, H1 2013
M2 - Tue Jul 16, 10:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wj83qr/cedar_pollen) has announced the addition of the "Cedar Pollen Allergy - Pipeline Review, H1 2013" report to their offering. 'Cedar Pollen Allergy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cedar Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cedar Pollen Allergy. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Cedar Pollen Allergy. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understand

House Dust Mite Allergy - Pipeline Review, H1 2013 Available Now
M2 - Tue Jun 04, 11:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sdngvg/house_dust_mite) has announced the addition of the "House Dust Mite Allergy - Pipeline Review, H1 2013" report to their offering. Global Markets Direct's, 'House Dust Mite Allergy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for House Dust Mite Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for House Dust Mite Allergy. House Dust Mite Allergy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for House Dust Mite Allergy. - A review of the House Dust Mite Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the House Dust Mite Allergy pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned: - ALK-Abello A/S - DBV Technologies - Stallergenes S.A. - Torii Pharmaceutical Co., Ltd. - Circassia Holdings Ltd. - Genetic Immunity, LLC - ANERGIS SA - Bial - Portela & Ca, S.A. - Biomay AG For more information visit http://www.researchandmarkets.com/research/sd..._dust_mite About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 64

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
U.S. Employers Signal a Deeper Multilingual Skills Gap

Updated Category News Views 15

A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...

Continue Reading
New York's $1.2M Prison Abuse Deal Raises State Stakes

Updated Category News Views 41

One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 95

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Arizona's Dry Climate Puts Scalp Health Under Stress

Updated Category News Views 35

Desert weather is unforgiving, and apparently the scalp does not get a pass. In a Nov. 20, 2026 discussion, Scottsdale and Tucson hair-restoration physician Dr. Sharon A. Keene frames Arizona hair concerns around something easy to overlook: the condition of the skin beneath the hair. That is a more sensible starting point than treating every strand in the shower like it...

Continue Reading
PetSmart Charities Adds Strategy Role for Pet Families

Updated Category News Views 347

A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...

Continue Reading
Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 10

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
Melio’s AP Push Looks Useful, but Read the Fine Print

Updated Category News Views 87

Back-office drudgery rarely gets anyone’s pulse racing, yet it can quietly chew through a small business’s time and cash. That is why Melio’s latest recognition as Software Experts’ top pick for accounts payable automation deserves a look. The product pitch is straightforward: pull bills, approvals, payments and reconciliation into one workflow rather than leaving...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 73

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
Hope Charities Makes Care Funding Easier to Track Online

Updated Category News Views 72

A treatment bill can wreck a household long before a diagnosis does. That is the uncomfortable reality behind Hope Charities' new Access to Care website, a centralized resource meant to show people in the bleeding disorders community when diagnosis-specific charitable assistance funds are available. This is not flashy technology, nor should it be treated like some grand...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Notary Journal Offers Streamlined Solutions

Updated Category News Views 108

Transforming Notary Services In the realm of notary services, efficiency and organization are paramount. An inventive spirit from Richmond has stepped forward, seeking to revolutionize the notary journal—a pivotal tool for professionals in this industry. The concept, aptly named the NOTARY JOURNAL, aims to streamline the process of recording signatures and vital...

Continue Reading
Cappfinity's Big Bet: Reshaping Leadership Impact

Updated Category News Views 20

Leadership Reimagined for a Changing World The market's no walk in the park right now, and Cappfinity’s stepping in with its new Leadership Contribution Platform to tackle the very thing that every organization’s biting nails over—leadership. We're talking about a total shift in how leadership’s gauged, understood, and developed. And yep, it’s about time someone...

Continue Reading
Spain Invests €19.6M in Quantix for Cybersecurity Hub

Updated Category News Views 239

Spain Boosts Cybersecurity Innovation with Quantix Investment The Spanish government's latest initiative aims to enhance cybersecurity and microelectronics innovation through an impressive investment of €19.6 million in Quantix. This investment is part of a broader effort to develop a cutting-edge Cybersecurity and Microelectronics Center in a strategic region....

Continue Reading
Innovative Income Strategies with New Simplify ETFs Launch

Updated Category News Views 232

Innovative Income Strategies with New Simplify ETFs Launch In a move designed to empower investors, Simplify Asset Management has introduced two innovative Exchange Traded Funds (ETFs) aimed at delivering capital-efficient exposure to gold and U.S. small-cap equities while generating consistent income. The newly launched funds are the Simplify Gold Strategy PLUS Income...

Continue Reading
California Takes Action Against Exxon Mobil for Plastic Waste

Updated Category News Views 121

California's Bold Move Against Exxon Mobil The state of California has initiated a major lawsuit against Exxon Mobil, one of the world's leading oil companies, accusing it of being complicit in the global plastic waste crisis. This legal action was announced by Attorney General Rob Bonta during an event focused on the necessity of climate action. Details of the Lawsuit...

Continue Reading